Tibet Pharmaceuticals Inc  

(Public, OTCMKTS:TBET)   Watch this stock  
Find more results for TBET
0.0100
0.0000 (0.00%)
May 22 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.01 - 0.01
52 week 0.00 - 0.24
Open 0.01
Vol / Avg. 1,500.00/9,806.00
Mkt cap 148,458.00
P/E 0.01
Div/yield     -
EPS 0.80
Shares 14.85M
Beta     -
Inst. own 0%

Key stats and ratios

Q3 (Sep '11) 2010
Net profit margin 19.18% 40.61%
Operating margin 18.81% 41.14%
EBITD margin - 43.92%
Return on average assets 13.19% 56.95%
Return on average equity 14.32% 77.26%
Employees 190 -
Carbon Disclosure Rating - -

Address

53 Niwang Rd, Shangri-La County
DIQING, YUN 674400
China
+86-887-8232158 (Phone)

External links

Discussion Group - Google Finance

Description

Tibet Pharmaceuticals, Inc., formerly Shangri-La Tibetan Pharmaceuticals, Inc., is a specialty pharmaceutical company focusing on the research, development, manufacturing and marketing of Tibetan medicines. The Company sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The Company sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company�s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.

Officers and directors

Hong Yu Chairman of the Board, Chief Executive Officer
Age: 50
Sabrina Y. Ren Chief Financial Officer
Age: 38
Solomon Chen Independent Director
Age: 33
Wenbo Chen Independent Director
Age: 74
Crystal Hang Independent Director
Age: 40
Youhang Peng Independent Director
Age: 51